Parker Geoffrey M. — SEC Form 4 filings

SEC reporting owner CIK 1491874. 21 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2024-01-31 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PERRIGO Co plc (PRGO)Director134 legs · 19,750 sh · $402,19423
Allogene Therapeutics, Inc. (ALLO)CHIEF FINANCIAL OFFICER81 leg · 190 sh · $6833 legs · 65,106 sh · $95,9558

Form 4 filings — Parker Geoffrey M.

FiledFormIssuerReported transactionsSource
2026-09-154PERRIGO Co plc (PRGO)Option exercise (M): 1,263 @ $13.66 · Tax withholding (F): 607 @ $13.66 · Option exercise (M): 1,263 (derivative)EDGAR
2026-06-164PERRIGO Co plc (PRGO)Option exercise (M): 976 @ $10.99 · Tax withholding (F): 469 @ $10.99 · Grant/award (A): 844 (derivative) · Option exercise (M): 976 (derivative)EDGAR
2026-05-154PERRIGO Co plc (PRGO)Option exercise (M): 7,305 @ $10.84 · Tax withholding (F): 3,507 @ $10.84 · Grant/award (A): 16,681 (derivative) · Option exercise (M): 7,305 (derivative)EDGAR
2026-03-174PERRIGO Co plc (PRGO)Grant/award (A): 3,024 (derivative)EDGAR
2026-02-044Allogene Therapeutics, Inc. (ALLO)Sale (S): 24,001 @ $1.76 · Grant/award (A): 539,072 (derivative) @ $0 · Grant/award (A): 152,480 (derivative) @ $0EDGAR
2025-12-164PERRIGO Co plc (PRGO)Grant/award (A): 2,140 (derivative)EDGAR
2025-11-144PERRIGO Co plc (PRGO)Purchase (P): 7,500 @ $14.18EDGAR
2025-10-234Allogene Therapeutics, Inc. (ALLO)Sale (S): 36,744 @ $1.26EDGAR
2025-09-164PERRIGO Co plc (PRGO)Grant/award (A): 1,263 (derivative)EDGAR
2025-08-204/APERRIGO Co plc (PRGO)Purchase (P): 4,375 @ $22.97EDGAR
2025-08-194PERRIGO Co plc (PRGO)Purchase (P): 4,375 @ $22.97EDGAR
2025-06-174PERRIGO Co plc (PRGO)Grant/award (A): 976 (derivative)EDGAR
2025-05-164PERRIGO Co plc (PRGO)Option exercise (M): 9,904 @ $26.01 · Tax withholding (F): 4,754 @ $26.01 · Grant/award (A): 7,305 (derivative) · Option exercise (M): 9,904 (derivative)EDGAR
2025-05-144PERRIGO Co plc (PRGO)Purchase (P): 3,500 @ $27.10EDGAR
2025-02-054Allogene Therapeutics, Inc. (ALLO)Sale (S): 4,361 @ $1.73EDGAR
2025-01-284Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 173,913 @ $0 · Grant/award (A): 614,844 (derivative) @ $0EDGAR
2024-10-234Allogene Therapeutics, Inc. (ALLO)Tax withholding (F): 36,404 @ $2.84EDGAR
2024-05-204Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 344,828 @ $2.90EDGAR
2024-05-164PERRIGO Co plc (PRGO)Option exercise (M): 8,764 @ $30.22 · Tax withholding (F): 4,207 @ $30.22 · Grant/award (A): 9,904 (derivative) · Option exercise (M): 8,764 (derivative)EDGAR
2024-03-064Allogene Therapeutics, Inc. (ALLO)Purchase (P): 190 @ $3.60EDGAR
2024-01-314Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 29,400 @ $0 · Grant/award (A): 103,939 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1491874 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →